Managing Enlarged Prostate: Diagnosis and Treatment Guidelines
Author Information
Author(s): Steven A Kaplan
Primary Institution: Weill Medical College of Cornell University
Hypothesis
The study aims to review the evaluation, diagnosis, and treatment strategies for enlarged prostate (EP).
Conclusion
Current guidelines emphasize the use of 5α-reductase inhibitors for managing enlarged prostate to prevent disease progression and improve symptoms.
Supporting Evidence
- 5α-reductase inhibitors can significantly reduce the risk of acute urinary retention.
- Treatment with dutasteride showed a 90.2% reduction in serum DHT levels.
- Combination therapy with α-blockers and 5α-reductase inhibitors is recommended for symptomatic patients.
Takeaway
Enlarged prostate is common in older men, and there are effective treatments that can help manage symptoms and slow down the disease.
Methodology
The study reviews existing literature and guidelines on the diagnosis and management of enlarged prostate, including a practical algorithm for treatment.
Potential Biases
Potential conflicts of interest due to author affiliations with pharmaceutical companies.
Limitations
The study primarily focuses on guidelines and may not cover all individual patient scenarios.
Participant Demographics
Men aged 40 years and older, with a focus on those between 50 and 79 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website